[Clinical aspects of secondary resistance in pulmonary tuberculosis].
作者信息
Gugić B
出版信息
Plucne Bolesti. 1985 Jan-Jun;37(1-2):22-7.
PMID:3934690
Abstract
摘要
相似文献
1
[Clinical aspects of secondary resistance in pulmonary tuberculosis].[肺结核继发性耐药的临床特点]
Plucne Bolesti. 1985 Jan-Jun;37(1-2):22-7.
2
[Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].[肺结核化学抗生素治疗的当前细菌学及临床方面]
Arch Monaldi. 1978 Jul-Aug;33(4):251-79.
3
[Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
Plucne Bolesti Tuberk. 1974;26 Suppl 2:29-37.
4
5
6
Risk factors for drug resistance in pulmonary tuberculosis inpatients.肺结核住院患者耐药的危险因素。
J Evid Based Med. 2010 Aug;3(3):162-7. doi: 10.1111/j.1756-5391.2010.01088.x.
7
[A study on prevalence of resistance to primary and secondary drugs among newly admitted pulmonary tuberculosis patients in 1977. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].1977年新收治肺结核患者对一线和二线药物耐药率的研究。第2部分。耐药率相关因素的研究（作者译）
Kekkaku. 1979 Dec;54(12):549-55.
8
[Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].[西班牙费罗尔地区结核分枝杆菌的耐药性。相关因素]
Med Clin (Barc). 1999 Nov 6;113(15):572-4.
9
[Incidence of drug resistance of Mycobacterium tuberculosis].[结核分枝杆菌的耐药发生率]
Vrach Delo. 1979 Mar(3):28-30.
Zotero 插件